Patents by Inventor Steven Sablotsky
Steven Sablotsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20010053383Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: ApplicationFiled: May 21, 2001Publication date: December 20, 2001Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 6235306Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: GrantFiled: March 23, 1999Date of Patent: May 22, 2001Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 6221383Abstract: A blend of at least two polymers, or at least one polymer and a soluble polyvinylpyrrolidone, in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin. According to the invention, soluble polyvinylpyrrolidone can be used to prevent crystallization of the drug, without affecting the rate of drug delivery from the pressure-sensitive adhesive composition.Type: GrantFiled: May 25, 1999Date of Patent: April 24, 2001Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 6024976Abstract: A blend of at least two polymers, or at least one polymer and a soluble polyvinylpyrrolidone, in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin. According to the invention, soluble polyvinylpyrrolidone can be used to prevent crystallization of the drug, without affecting the rate of drug delivery from the pressure-sensitive adhesive composition.Type: GrantFiled: August 11, 1997Date of Patent: February 15, 2000Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5958446Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: GrantFiled: May 4, 1995Date of Patent: September 28, 1999Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5719197Abstract: Compositions for topical application comprising a therapeutically effective amount of a pharmaceutical agent(s), a pharmaceutically acceptable bioadhesive carrier, a solvent for the pharmaceutical agent(s) in the carrier and a clay, and methods of administering the pharmaceutical agents to a mammal are disclosed.Type: GrantFiled: June 7, 1995Date of Patent: February 17, 1998Assignee: Noven Pharmaceuticals, Inc.Inventors: David P. Kanios, Joseph A. Gentile, Juan A. Mantelle, Steven Sablotsky
-
Patent number: 5686099Abstract: A method of increasing the adhesiveness of a shaped pressure sensitive adhesive, comprising adding an adhesiveness and drug release increasing amount of a clay to said adhesive prior to casting of the adhesive.A dermal composition comprising a drug, a pressure sensitive adhesive, an adhesiveness increasing amount of a clay and a solvent.A dermal composition comprising a drug, a multipolymer of ethylene vinyl acetate, an acrylic polymer, a natural or synthetic rubber and a clay, along with optional ingredients known for use in transdermal drug delivery systems.Type: GrantFiled: May 26, 1993Date of Patent: November 11, 1997Assignee: Noven Pharmaceuticals, Inc.Inventors: Steven Sablotsky, Joseph A. Gentile
-
Patent number: 5656285Abstract: Disclosed is a method and apparatus for forming a transdermal drug delivery device from a multilayer web comprised of a backing layer, a drug-containing pressure sensitive adhesive layer, and a release layer or liner in which cutting is progressively achieved along a line coplanar with the axes of a cutting roller and anvil roller counter-rotating in proximity to each other. In one embodiment, cutting is achieved completely through the web about the periphery of the transdermal drug delivery device, while simultaneously achieving a scoring only of the release liner without penetration of the pressure sensitive adhesive layer or backing layer. In an alternate embodiment there are two arrangements of rollers. A first arrangement has a cutting edge for scoring the web. After scoring, the web is passed to a second arrangement for cutting through the web to result in the transdermal drug delivery device.Type: GrantFiled: April 6, 1995Date of Patent: August 12, 1997Assignee: Noven Pharmaceuticals, Inc.Inventors: Steven Sablotsky, Ronald E. LaPrade
-
Patent number: 5656286Abstract: A blend of at least two polymers, or at least one polymer and a soluble polyvinylpyrrolidone, in combination with a drug provides a pressure-sensitive adhesive composition for a transdermal drug delivery system in which the drug is delivered from the pressure-sensitive adhesive composition and through dermis when the pressure-sensitive adhesive composition is in contact with human skin. According to the invention, soluble polyvinylpyrrolidone can be used to prevent crystallization of the drug, without affecting the rate of drug delivery from the pressure-sensitive adhesive composition.Type: GrantFiled: January 7, 1994Date of Patent: August 12, 1997Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5474783Abstract: The method of adjusting the saturation concentration of a drug in a transdermal composition for application to the dermis, which comprises mixing polymers having differing solubility parameters, so as to modulate the delivery of the drug. This results in the ability to achieve a predetermined permeation rate of the drug into and through the dermis. In one embodiment, a dermal composition of the present invention comprises a drug, an acrylate polymer, and a polysiloxane. The dermal compositions can be produced by a variety of methods known in the preparation of drug-containing adhesive preparations, including the mixing of the polymers, drug, and additional ingredients in solution, followed by removal of the processing solvents. The method and composition of this invention permit selectable loading of the drug into the dermal formulation and adjustment of the delivery rate of the drug from the composition through the dermis, while maintaining acceptable shear, tack, and peel adhesive properties.Type: GrantFiled: June 27, 1991Date of Patent: December 12, 1995Assignee: Noven Pharmaceuticals, Inc.Inventors: Jesus Miranda, Steven Sablotsky
-
Patent number: 5405486Abstract: Disclosed is a method and apparatus for forming a transdermal drug delivery device from a multilayer web comprised of a backing layer, a drug-containing pressure sensitive adhesive layer, and a release layer or liner in which cutting is progressively achieved along a line coplanar with the axes of a cutting roller and anvil roller counter-rotating in proximity to each other. In one embodiment, cutting is achieved completely through the web about the periphery of the transdermal drug delivery device, while simultaneously achieving a scoring only of the release liner without penetration of the pressure sensitive adhesive layer or backing layer. In an alternate embodiment there are two arrangements of rollers. A first arrangement has a cutting edge for scoring the web. After scoring, the web is passed to a second arrangement for cutting through the web to result in the transdermal drug delivery device.Type: GrantFiled: June 21, 1993Date of Patent: April 11, 1995Assignee: Noven Pharmaceuticals, Inc.Inventors: Steven Sablotsky, Ronald E. LaPrade
-
Patent number: 5300291Abstract: A method of increasing the adhesiveness of a shaped pressure sensitive adhesive, comprising adding an adhesiveness and drug release increasing amount of a clay to said adhesive prior to casting of the adhesive.A dermal composition comprising a drug, a pressure sensitive adhesive, an adhesiveness increasing amount of a clay and a solvent.A dermal composition comprising a drug, a multipolymer of ethylene vinyl acetate, an acrylic polymer, a natural or synthetic rubber and a clay, along with optional ingredients known for use in transdermal drug delivery systems.Type: GrantFiled: April 2, 1991Date of Patent: April 5, 1994Assignee: Noven Pharmaceuticals, Inc.Inventors: Steven Sablotsky, Joseph A. Gentile
-
Patent number: 5186938Abstract: An adhesive bilayer transdermal dosage system capable of sustained release of a pharmaceutically active drug to the skin of a human patient having a first component layer which is a pharmaceutically active drug-containing essentially planar sheet of an at least partially cross-linked acrylic adhesive. The planar sheet is formed of a flexible self-supporting cross-linked acrylate of sufficient adhesivity, durability and strength whereby intimate diffusional contact with the skin of the patient is maintained for a period of at least about 24 hours without destruction of the physical integrity of the sheet. The sheet is capable of retaining, dispersed therein, sufficient pharmaceutically active drug to deliver to the skin a pharmaceutically effective amount of the drug over a 24-hour period without dissolution of the at least partially crosss-linked acrylic adhesive. The system also contains a second component layer intimately adhered to one side of the first component layer.Type: GrantFiled: August 7, 1991Date of Patent: February 16, 1993Assignee: Key Pharmaceuticals, Inc.Inventors: Steven Sablotsky, John M. Questel, James A. Thompson
-
Patent number: 5032207Abstract: A one step method and apparatus for forming a pressure sensitive adhesive transdermal drug device having a scored release liner which comprises positioning a web containing the release liner using a cutting die having a first cutting element designed to completely cut through the web to form the device and a second cutting element designed to cut only the release liner.Type: GrantFiled: September 15, 1989Date of Patent: July 16, 1991Assignee: Noven Pharmaceuticals, Inc.Inventors: Steven Sablotsky, Ronald E. LaPrade
-
Patent number: 4994278Abstract: A composition comprising a flexible backing for a transdermal drug preparation with a water vapor transmission rate about equal to or in excess of that of ethylene vinyl alcohol copolymer, namely equal to or in excess of, at one mil thickness, of about 2 to 4 grams and more preferably in excess of 6 grams per 24 hours per 100 square inches at 40.degree. C. and 90% relative humidity and an oxygen transmission rate equal to or less than ethylene vinyl alcohol copolymer, namely at one mil thickness equal to or less than about 0.01 to 0.1 cubic centimeters per 100 square inches measured over 24 hours at 1 atmospheric pressure, 20.degree. C. and 65% relative humidity.Type: GrantFiled: January 11, 1989Date of Patent: February 19, 1991Assignee: Noven Pharmaceuticals, Inc.Inventors: Steven Sablotsky, Cheryl M. Gentile
-
Patent number: 4994267Abstract: A dermal composition comprising a drug, a multipolymer of ethylene-vinyl acetate, an acrylic polymer, and optionally one or more monomers, a natural or synthetic rubber and a tackifying agent. The ratio of the multipolymer to the rubber is, respectively, about 1:1 to about 10:1 and more preferably, 1:1 to 5:1 and more preferably 3:1. The dermal composition can optionally contain a crosslinking agent, tackifiers, penetration enhancers and other ingredients known for use in adhesives for the transdermal delivery of drugs. The dermal compositions can be produced by a variety of methods known in the preparation of drug containing adhesive preparations including the homogenous mixing of the multipolymer, drug and optional crosslinking agent and additional ingredients in solution or suspension or emulsion followed by removal of excess solvent.Type: GrantFiled: January 11, 1989Date of Patent: February 19, 1991Assignee: Noven Pharmaceuticals, Inc.Inventor: Steven Sablotsky
-
Patent number: 4814168Abstract: A dermal compositon comprising a drug, a multi-polymer of vinyl acetate, polyethylene and optionally one or more monomers, a natural or synthetic rubber and a tackifying agent. The ratio of the multipolymer to the rubber is, respectively, about 1:1 to about 10:1 and more preferably 1:1 to 5:1 and more preferably 3:1. The dermal composition can optionally contain a crosslinking agent, tackifiers, penetration enhancers and other ingredients known for use in adhesives for the transdermal delivery of drugs. The dermal compositions can be produced by a variety of methods known in the preparation of drug containing adhesive preparations including the homogenous mixing of the multi-polymer, drug and optional crosslinking agent and additional ingredients in aqueous solution followed by removal of excess water.Type: GrantFiled: March 4, 1988Date of Patent: March 21, 1989Assignee: Noven Pharmaceuticals, Inc.Inventors: Steven Sablotsky, John M. Questel, Dorothy J. Leeson
-
Patent number: 4585452Abstract: Sustained release dosage forms that provide transdermal delivery of drugs utilizing the skin as the rate controlling membrane for the drugs. Methods for producing the dosage forms are also disclosed. The dosage forms are laminates produced by heating a laminate to a glass transition temperature of an outer removable layer of the laminate. While maintaining the laminate at the glass transition temperature, a vacuum is applied to draw the laminate into a suitable shape for a drug reservoir. An aqueous solvent is added to the reservoir and a semipermeable barrier layer is placed over the aqueous solvent in the reservoir. A pharmaceutically active drug is contained in the aqueous reservoir and this drug moves transdermally to provide the active ingredient to the patient.Type: GrantFiled: April 12, 1983Date of Patent: April 29, 1986Assignee: Key Pharmaceuticals, Inc.Inventor: Steven Sablotsky